American Action Forum Issues Commentary: Section 232 Pharmaceutical Tariffs Are Not a Health Policy Tool
April 07, 2026
April 07, 2026
WASHINGTON, April 7 -- The American Action Forum issued the following commentary on April 6, 2026, by Health Care Policy Director Michael Baker:
* * *
Section 232 Pharmaceutical Tariffs Are Not a Health Policy Tool
Executive Summary
* The Trump Administration announced a new Section 232 tariff regime targeting patented pharmaceuticals and associated pharmaceutical ingredients, tying the policy to both manufacturing onshoring and most-favored-na . . .
* * *
Section 232 Pharmaceutical Tariffs Are Not a Health Policy Tool
Executive Summary
* The Trump Administration announced a new Section 232 tariff regime targeting patented pharmaceuticals and associated pharmaceutical ingredients, tying the policy to both manufacturing onshoring and most-favored-na . . .
